Economic evaluation of general childhood vaccination against Haemophilus influenzae type b in Sweden.
The objective of the study was to evaluate the economic consequences of a general childhood vaccination programme against Haemophilus influenzae type b (Hib) in Sweden. A retrospective pre-vaccination annual cohort of 0-4-y-old children was compared with an annual cohort of the same age group after a complete implemented vaccination program against Hib. The cost analysis shows that vaccination against Hib is cost saving when indirect costs are included in the analysis. In the cost-benefit analysis it is shown that society will gain approximately 88 million Swedish Crowns (SEK) annually when Hib vaccination is totally implemented. In conclusion, general childhood Hib vaccination is a cost-effective public health intervention in Swedish society.
Garpenholt
O
O
Department of Clinical Microbiology, Orebro Medical Centre Hospital, Sweden.
Silfverdal
S A
SA
Levin
L A
LA
D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D006192:Haemophilus Infections / Q000191:economics / Q000517:prevention & control*; D018073:Haemophilus Vaccines / Q000191:economics; D019741:Haemophilus influenzae type b / Q000276:immunology; D006801:Humans; D007223:Infant; D013548:Sweden; D014611:Vaccination / Q000191:economics*
D018073:Haemophilus Vaccines